标题
Pharmacogenomics of lipid-lowering therapies
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 14, Issue 8, Pages 981-995
出版商
Future Medicine Ltd
发表日期
2013-06-07
DOI
10.2217/pgs.13.71
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genome-Wide Association Study Evaluating Lipoprotein-Associated Phospholipase A 2 Mass and Activity at Baseline and After Rosuvastatin Therapy
- (2012) Audrey Y. Chu et al. Circulation-Cardiovascular Genetics
- Pharmacogenetic Determinants of Statin-Induced Reductions in C-Reactive Protein
- (2012) Audrey Y. Chu et al. Circulation-Cardiovascular Genetics
- Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction
- (2012) Daniel I. Chasman et al. Circulation-Cardiovascular Genetics
- Understanding the Critical Disposition Pathways of Statins to Assess Drug–Drug Interaction Risk During Drug Development: It's Not Just About OATP1B1
- (2012) R Elsby et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Whole-Genome Sequencing in Personalized Therapeutics
- (2012) P Cordero et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy
- (2012) R A Wilke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study
- (2012) Jemma C. Hopewell et al. EUROPEAN HEART JOURNAL
- LPLgene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia
- (2012) Ariel Brautbar et al. JOURNAL OF LIPID RESEARCH
- Liver fat reduction with niacin is influenced byDGAT-2polymorphisms in hypertriglyceridemic patients
- (2012) Miao Hu et al. JOURNAL OF LIPID RESEARCH
- Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
- (2012) Harshal A. Deshmukh et al. JOURNAL OF LIPID RESEARCH
- Statins for people at low risk of cardiovascular disease – Authors' reply
- (2012) Borislava Mihaylova et al. LANCET
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network
- (2012) Stella Aslibekyan et al. Pharmacogenetics and Genomics
- Pharmacogenetics of statins: achievements, whole-genome analyses and future perspectives
- (2012) Iris Postmus et al. PHARMACOGENOMICS
- Associations between the genotypes and phenotype of CYP3A and the lipid response to simvastatin in Chinese patients with hypercholesterolemia
- (2012) Miao Hu et al. PHARMACOGENOMICS
- Genome-Wide Study of Gene Variants Associated with Differential Cardiovascular Event Reduction by Pravastatin Therapy
- (2012) Dov Shiffman et al. PLoS One
- Clinical response to statins: Mechanism(s) of variable activity and adverse effects
- (2011) Cesare R. Sirtori et al. ANNALS OF MEDICINE
- Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia
- (2011) Ariel Brautbar et al. ATHEROSCLEROSIS
- Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and cardiovascular risk and efficacy of atorvastatin among subjects with diabetes on dialysis: The 4D study
- (2011) Michael M. Hoffmann et al. ATHEROSCLEROSIS
- Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI
- (2011) Bas J.M. Peters et al. ATHEROSCLEROSIS
- Kinesin-Like Protein 6 (KIF6) Polymorphism and the Efficacy of Rosuvastatin in Primary Prevention
- (2011) Paul M Ridker et al. Circulation-Cardiovascular Genetics
- The 719Arg Variant of KIF6 and Cardiovascular Outcomes in Statin-Treated, Stable Coronary Patients of the Treating to New Targets and Incremental Decrease in End Points Through Aggressive Lipid-Lowering Prospective Studies
- (2011) Benoit J. Arsenault et al. Circulation-Cardiovascular Genetics
- Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials
- (2011) L. A. Leiter et al. DIABETES OBESITY & METABOLISM
- SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia
- (2011) Paulo Caleb Junior Lima Santos et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Is there clinical benefit to routine enzyme testing of patients on statins?
- (2011) Asher Elhayany et al. Expert Opinion On Drug Safety
- The Effect of CYP7A1 Polymorphisms on Lipid Responses to Fenofibrate
- (2011) Jian Shen et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- No Impact of KIF6 Genotype on Vascular Risk and Statin Response Among 18,348 Randomized Patients in the Heart Protection Study
- (2011) Jemma C. Hopewell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of currently prescribed LDL-C-lowering drugs on PCSK9 and implications for the next generation of LDL-C-lowering agents
- (2011) Robert J Konrad et al. Lipids in Health and Disease
- Association of common variants in the human eyes shut ortholog (EYS) with statin-induced myopathy: Evidence for additional functions of EYS
- (2011) Paul J. Isackson et al. MUSCLE & NERVE
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia
- (2011) L. Pisciotta et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Cerivastatin, genetic variants, and the risk of rhabdomyolysis
- (2011) Kristin D. Marciante et al. Pharmacogenetics and Genomics
- Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in The Rotterdam Study
- (2011) Laure Elens et al. Pharmacogenetics and Genomics
- Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin
- (2011) L R Brunham et al. PHARMACOGENOMICS JOURNAL
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
- (2011) M. Niemi et al. PHARMACOLOGICAL REVIEWS
- The Pleiotropic Effects of the Hydroxy-Methyl-Glutaryl-CoA Reductase Inhibitors in Cardiovascular Disease
- (2010) Christos G. Mihos et al. Cardiology in Review
- Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction
- (2010) Kristian M. Bailey et al. Circulation-Cardiovascular Genetics
- Apolipoprotein E Polymorphisms and Postprandial Triglyceridemia Before and After Fenofibrate Treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study
- (2010) Marguerite R. Irvin et al. Circulation-Cardiovascular Genetics
- Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study
- (2010) L A Donnelly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin
- (2010) B Tomlinson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Ezetimibe; More Than a Low Density Lipoprotein Cholesterol Lowering Drug? An Update After 4 Years
- (2010) Eirini Lioudaki et al. Current Vascular Pharmacology
- Lipoprotein(a) as a cardiovascular risk factor: current status
- (2010) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins
- (2010) Miao Hu et al. Expert Opinion on Drug Metabolism & Toxicology
- Efflux and uptake transporters as determinants of statin response
- (2010) Alice C Rodrigues Expert Opinion on Drug Metabolism & Toxicology
- Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study
- (2010) Mary K. Wojczynski et al. JOURNAL OF LIPID RESEARCH
- Lack of Association Between the Trp719Arg Polymorphism in Kinesin-Like Protein-6 and Coronary Artery Disease in 19 Case-Control Studies
- (2010) Themistocles L. Assimes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
- (2010) LANCET
- Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients
- (2010) Miao Hu et al. Pharmacogenetics and Genomics
- Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs
- (2010) D Wang et al. PHARMACOGENOMICS JOURNAL
- Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
- (2010) M. John Chapman et al. PHARMACOLOGY & THERAPEUTICS
- Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations
- (2010) Mathew J. Barber et al. PLoS One
- Identification of Genetic Variants Associated With Response to Statin Therapy
- (2009) Jessica L. Mega et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The −1131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome: A postprandial study
- (2009) Fernando Cardona et al. ATHEROSCLEROSIS
- Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE alleles
- (2009) Giuseppe Danilo Norata et al. ATHEROSCLEROSIS
- Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) Cohort
- (2009) John F. Thompson et al. Circulation-Cardiovascular Genetics
- Transporter Pharmacogenetics and Statin Toxicity
- (2009) M Niemi CLINICAL PHARMACOLOGY & THERAPEUTICS
- ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
- (2009) J E Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease
- (2009) Marianne Abifadel et al. HUMAN MUTATION
- The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis
- (2009) S. A. Mousavi et al. JOURNAL OF INTERNAL MEDICINE
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
- (2009) Deepak Voora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the Genetics of Lipid-Lowering Drugs and Diet Network study
- (2009) Yongjun Liu et al. Pharmacogenetics and Genomics
- Common sequence variant in lipoprotein lipase gene conferring triglyceride response to fibrate treatment
- (2009) Kuo-Liong Chien et al. PHARMACOGENOMICS
- Different effects of theABCG2c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin
- (2009) Jenni E Keskitalo et al. PHARMACOGENOMICS
- The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy
- (2009) S P R Romaine et al. PHARMACOGENOMICS JOURNAL
- Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states
- (2008) Pablo Perez-Martinez et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER
- (2008) Eliana Polisecki et al. ATHEROSCLEROSIS
- Variation in the 3-Hydroxyl-3-Methylglutaryl Coenzyme A Reductase Gene Is Associated With Racial Differences in Low-Density Lipoprotein Cholesterol Response to Simvastatin Treatment
- (2008) Ronald M. Krauss et al. CIRCULATION
- Pharmacogenetic Predictors of Statin-Mediated Low-Density Lipoprotein Cholesterol Reduction and Dose Response
- (2008) Deepak Voora et al. Circulation-Cardiovascular Genetics
- Pharmacokinetic Comparison of the Potential Over-the-Counter Statins Simvastatin, Lovastatin, Fluvastatin and Pravastatin
- (2008) Pertti J Neuvonen et al. CLINICAL PHARMACOKINETICS
- Association of Common C-Reactive Protein (CRP) Gene Polymorphisms With Baseline Plasma CRP Levels and Fenofibrate Response: The GOLDN Study
- (2008) J. Shen et al. DIABETES CARE
- The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment
- (2008) Jennifer A Smith et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- The SCARB1 gene is associated with lipid response to dietary and pharmacological interventions
- (2008) Yongjun Liu et al. JOURNAL OF HUMAN GENETICS
- A Kinesin Family Member 6 Variant Is Associated With Coronary Heart Disease in the Women’s Health Study
- (2008) Dov Shiffman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of the Trp719Arg Polymorphism in Kinesin-Like Protein 6 With Myocardial Infarction and Coronary Heart Disease in 2 Prospective Trials
- (2008) Olga A. Iakoubova et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Polymorphism in KIF6 Gene and Benefit From Statins After Acute Coronary Syndromes
- (2008) Olga A. Iakoubova et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease
- (2008) Tuomo Nieminen et al. PHARMACOGENOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search